H. Trattner

发表

Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study

A. Geroldinger, A. Tanew, S. Tzaneva, 2018, The British journal of dermatology.

Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis

Kaspar Torz, S. Kõks, A. Burden, 2020, JAMA dermatology.

Idiopathic hypereosinophilic syndrome with multiple organ infarction: improvement of the skin condition masking the course of disease

F. Breier, A. Steiner, R. Feldmann, 2014, European Journal of Dermatology.

Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)

R. Müllegger, W. Weger, P. Wolf, 2022, Scientific Reports.

Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis

W. Hoetzenecker, R. Müllegger, W. Weger, 2020, JAAD international.

Clinical and genetic differences between pustular psoriasis subtypes

Kaspar Torz, A. Burden, N. Reynolds, 2018, The Journal of allergy and clinical immunology.

Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*

W. Hoetzenecker, R. Müllegger, W. Weger, 2020, The British journal of dermatology.

Quality of life and comorbidities in palmoplantar pustulosis – a cross‐sectional study on 102 patients

S. Blüml, I. Steiner, A. Tanew, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.